Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 259-869-1 | CAS number: 55860-53-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- other: published data
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Justification for type of information:
- Dithiocarbamates are related compounds to Thionocarbamate.
- Objective of study:
- metabolism
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 85-1 (Metabolism and Pharmacokinetics)
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EU Method B.36 (Toxicokinetics)
- Deviations:
- yes
- Remarks:
- Distribution was not investigated.
- GLP compliance:
- yes
- Radiolabelling:
- yes
- Remarks:
- 14C-Ziram
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- - Source: Charles River, US
- Age at study initiation: 44 days (m); 51 days (f)
- Weight at study initiation: 149-169 g (m); 145-162 g (f) - Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Duration and frequency of treatment / exposure:
- Single and multiple (15 days daily) application
- Remarks:
- Doses / Concentrations:
Single: 15 and 352 mg/kg
Multiple: 15 mg/kg (14x nonradiolabeled; 1x radiolabeled) - No. of animals per sex per dose / concentration:
- 5
- Control animals:
- yes, concurrent vehicle
- Details on dosing and sampling:
- - Tissues and body fluids sampled: air, urine, faeces, blood, several organs
The CO2 trapping solution and the volatile traps were collected at 0-4, 4-8, 8-12, and 12-24 h following administration of the radiolabeled Ziram and daily thereafter for a total of 4 days. Urine and faeces samples were collected at 0-6, 6-12, and 12-24 hours after the radiolabeled dose and daily thereafter for a total of 7 days. Urine and faeces were collected in plastic containers surrounded by ice. At the end of the collection period, the animals were anesthetized with halothane and exsanguinated by cardiac puncture. Blood (2 to 5 mL) was collected and weighed in heparinized tubes and saved for radioanalysis. After sacrifice the cages were washed with a 1.0% trisodium phosphate solution which was saved for analysis. - Details on absorption:
- The mean 14C recovery ranged from 79% to 92% of the total doses administered.
- Details on distribution in tissues:
- The mean total radioactivity retained in the tissues and carcasses ranged from 1.11% to 1.92% of the total dose administered. For the low dose groups, the residue levels in the blood and tissues ranged from 0.05 to 2.5 ppm (µg 14C-Ziram equivalents/g sample). The highest levels were found in blood, liver, kidney, heart, lungs, spleen and thyroid gland.
- Details on excretion:
- The majority of the radioactivity was found in urine (17% to 35%), faeces (9% to 18%), and expired air (36% to 53%). The rate of elimination was relatively fast; the majority of the radioactivity was eliminated within 48 hours after dosing.
No apparent sex-related differences were observed for 14C elimination or distribution for any of the treated groups. - Metabolites identified:
- yes
- Conclusions:
- Interpretation of results : no bioaccumulation potential based on study results
Dithiocarbamates are related compounds to Thionocarbamate .
The mean total radioactivity retained in the tissues and carcasses ranged from 1.11% to 1.92% of the total dose administered. For the low dose groups, the residue levels in the blood and tissues ranged from 0.05 to 2.5 ppm (µg 14C-Ziram equivalents/g sample). The highest levels were found in blood, liver, kidney, heart, lungs, spleen and thyroid gland. - Endpoint:
- basic toxicokinetics in vivo
- Data waiving:
- other justification
- Justification for data waiving:
- other:
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- other: published data
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Justification for type of information:
- Isobutyl alcohol is reagents used in the manufacture of O-isobutyl ethylthiocarbamate.Therefore, the health effects of Isobutyl alcohol need to be considered in the assessment of O-isobutyl ethylthiocarbamate .
- Objective of study:
- metabolism
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- In an effort to understand the elimination kinetics of aliphatic alcohols found in alcoholic beverages, research was conducted with human subjects.
Test subjects consumed isobutanol in an ethanol/water vehicle over a two hour time period. Blood and urine samples were collected prior to consumption, at the end of the two-hour consumption period, at one, two, eight (urine only), and nine hours after the end of the exposure period. - GLP compliance:
- no
- Radiolabelling:
- no
- Species:
- other: human
- Strain:
- not specified
- Sex:
- not specified
- Route of administration:
- other: oral by drinking
- Vehicle:
- other: orange juice
- Duration and frequency of treatment / exposure:
- 2 hours followed by 9 hours of post exposure
- Remarks:
- Doses / Concentrations:
not specified - No. of animals per sex per dose / concentration:
- not specified
- Control animals:
- not specified
- Positive control reference chemical:
- None.
- Metabolites identified:
- yes
- Details on metabolites:
- isobutyraldehyde and isobutyric acid
The blood concentrations of isobutanol, isobutyraldehyde, and isobutyric acid were approximately 4, 4, and 17 µmol/L at the end of the consumption period, clearly demonstrating that isobutyric acid was the major metabolite of isobutanol metabolism. While the addition of ethanol to the test beverage definitely altered the rate of isobutanol metabolism (via a competition for metabolic enzymes), the presence of ethanol did not affect how isobutanol was metabolized. Blood levels of isobutanol decreased over the next two hours while the isobutyraldehyde levels slowly increased in the blood. Isobutyric acid levels also decreased after the end of the consumption period. Urinary concentrations of isobutanol peaked at the one-hour postexposure time point. Urinary levels of isobutyraldehyde peaked at the eight hour post-exposure time point. Urinary levels of isobutyric acid peaked at the end of the two-hour exposure period. Urinary levels of propionaldehyde roughly followed those for isobutyraldehyde with peak levels of approximately 8 µmol/L. Urinary levels of propionic acid rose after the exposure period ended with plateau levels between 2 and 8 hours of approximately 60 µmol/L. Urinary levels of succinic acid roughly followed the propionic acid urinary elimination curve with peak levels of approximately 30 µmol/L. A diagram was provided in the paper describing the further metabolism of isobutyric acid, ending with propionic acid. The formation of succinic acid from propionic acid is proposed based on the known intermediate metabolism of propionic acid via the citric acid cycle - Conclusions:
- Interpretation of results: no bioaccumulation potential based on study results
No bioaccumulation potential based on study results for Isobutyl alcohol
Isobutyl alcohol is reagents used in the manufacture of O-isobutyl ethylthiocarbamate.Therefore, the health effects of Isobutyl alcohol need to be considered in the assessment of O-isobutyl ethylthiocarbamate . - Endpoint:
- dermal absorption in vivo
- Type of information:
- (Q)SAR
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- results derived from a valid (Q)SAR model and falling into its applicability domain, with adequate and reliable documentation / justification
- Justification for type of information:
- QSAR prediction:US EPA accepted QSAR method for chemicals properties assessment.
- Qualifier:
- no guideline required
- Principles of method if other than guideline:
- Using the DERMWIN v2.01 QSAR model
- GLP compliance:
- no
- Remarks:
- not applicable to QSAR models
- Radiolabelling:
- no
- Species:
- other: QSAR model,
- Strain:
- other: QSAR model,
- Sex:
- not specified
- Type of coverage:
- other: QSAR model
- Vehicle:
- other: QSAR model
- Duration of exposure:
- not applicable to QSAR models
- Doses:
- not applicable to QSAR models
- No. of animals per group:
- not applicable to QSAR models
- Control animals:
- no
- Details on study design:
- not applicable to QSAR models
- Details on in vitro test system (if applicable):
- not applicable to QSAR models
- Signs and symptoms of toxicity:
- not specified
- Dermal irritation:
- not specified
- Absorption in different matrices:
- A QSAR model predicts that the permeability of O-isobutyl ethylthiocarbamate (IBETC) to human skin is quite low. The permeability coefficient was determined to be 0.00487 mg/cm2, which is around 1% of the skin penetration rate.
Predicted dermally absorbed coefficient was determined to be Kp (est)=00.0663 cm/hr - Conclusions:
- A QSAR model predicts that the permeability of O-isobutyl ethylthiocarbamate (IBETC) to human skin is quite low. The permeability coefficient was determined to be 0.00487 mg/cm2, which is around 1% of the skin penetration rate.
Predicted dermally absorbed coefficient was determined to be Kp (est)=00.0663 cm/hr - Executive summary:
A QSAR model predicts that the permeability of O-isobutyl ethylthiocarbamate (IBETC) to human skin is quite low. The permeability coefficient was determined to be 0.00487 mg/cm2, which is around 1% of the skin penetration rate.
Predicted dermally absorbed coefficient was determined to be Kp (est)=00.0663 cm/hr
- Endpoint:
- dermal absorption in vivo
- Type of information:
- other: published dara
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Justification for type of information:
- Dithiocarbamates are related compounds to Thionocarbamate.
- Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 427 (Skin Absorption: In Vivo Method)
- Deviations:
- yes
- Remarks:
- Recovery was not in the required range. Volatile 14C-compounds were not collected.
- GLP compliance:
- yes
- Radiolabelling:
- yes
- Remarks:
- (14C)-Ziram
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- - Source: Charles River Laboratories, Wilmington, Massachusetts, US
- Weight: 237-267 g (Individual data of control group not reported) - Type of coverage:
- open
- Vehicle:
- water
- Duration of exposure:
- 0.5, 1, 2, 4, 10 and 24 h
- Doses:
- 1.2, 9.9, 57.1% (w/v)
- No. of animals per group:
- 4 per timepoint
- Control animals:
- yes
- Signs and symptoms of toxicity:
- no effects
- Dermal irritation:
- not examined
- Absorption in different matrices:
- see Table 6_2-1
- Total recovery:
- see Table 6_2-1
- Dose:
- 0.086 mg/cm²
- Parameter:
- percentage
- Absorption:
- 28.5 %
- Remarks on result:
- other: 24 h
- Dose:
- 0.95 mg/cm²
- Parameter:
- percentage
- Absorption:
- 30.7 %
- Remarks on result:
- other: 24 h
- Dose:
- 7.25 mg/cm²
- Parameter:
- percentage
- Absorption:
- 4.89 %
- Remarks on result:
- other: 24 h
- Conclusions:
- Dithiocarbamates are related compounds to Thionocarbamate.
Less than 0.3% of the administered radiolabel was retained in the carcass and was eliminated in the excreta within 24 h after exposure.
The mean amount absorbed (sum of radiolabel in urine, carcass, and skin at the test site) by 24 h was 29% of the administered dose in animals at 1.1 mg, 31% in those at 12 mg, and 5% for those at 91 mg, indicating non-linear dermal absorption. - Executive summary:
Less than 0.3% of the administered radiolabel was retained in the carcass and was eliminated in the excreta within 24 h after exposure. The mean amount absorbed (sum of radiolabel in urine, carcass, and skin at the test site) by 24 h was 29% of the administered dose in animals at 1.1 mg, 31% in those at 12 mg, and 5% for those at 91 mg, indicating non-linear dermal absorption.
Referenceopen allclose all
The blood concentrations of isobutanol, isobutyraldehyde, and isobutyric acid were approximately 4, 4, and 17 µmol/L at the end of the consumption period, clearly demonstrating that isobutyric acid was the major metabolite of isobutanol metabolism. While the addition of ethanol to the test beverage definitely altered the rate of isobutanol metabolism (via a competition for metabolic enzymes), the presence of ethanol did not affect how isobutanol was metabolized. Blood levels of isobutanol decreased over the next two hours while the isobutyraldehyde levels slowly increased in the blood. Isobutyric acid levels also decreased after the end of the consumption period. Urinary concentrations of isobutanol peaked at the one-hour postexposure time point. Urinary levels of isobutyraldehyde peaked at the eight hour post-exposure time point. Urinary levels of isobutyric acid peaked at the end of the two-hour exposure period. Urinary levels of propionaldehyde roughly followed those for isobutyraldehyde with peak levels of approximately 8 µmol/L. Urinary levels of propionic acid rose after the exposure period ended with plateau levels between 2 and 8 hours of approximately 60 µmol/L. Urinary levels of succinic acid roughly followed the propionic acid urinary elimination curve with peak levels of approximately 30 µmol/L. A diagram was provided in the paper describing the further metabolism of isobutyric acid, ending with propionic acid. The formation of succinic acid from propionic acid is proposed based on the known intermediate metabolism of propionic acid via the citric acid cycle
A QSAR model predicts that the permeability of O-isobutyl ethylthiocarbamate (IBETC) to human skin is quite low. The permeability coefficient was determined to be 0.00487 mg/cm2, which is around 1% of the skin penetration rate.
Predicted dermally absorbed coefficient was determined to be Kp (est)=00.0663 cm/hr
Table A6_2-1: Mean recovery of radioactivity from male rats following a single dermal application of (14C)-ziram |
||||||||||||||||||
Parameter /Tissue |
1.07 mg/rat |
11.9 mg/rat |
90.6 mg/rat |
|||||||||||||||
[%] of administered dose |
||||||||||||||||||
0.5 h |
1 h |
2 h |
4 h |
10 h |
24 h |
0.5 h |
1 h |
2 h |
4 h |
10 h |
24 h |
0.5 h |
1 h |
2 h |
4 h |
10 h |
24 h |
|
Skin rinse |
75.22 |
85.35 |
78.90 |
74.64 |
70.07 |
70.53 |
72.39 |
69.03 |
67.03 |
60.71 |
72.33 |
68.79 |
101.96 |
99.79 |
99.73 |
97.20 |
100.26 |
93.49 |
Skin cell cover |
0.06 |
0.08 |
0.12 |
0.12 |
0.26 |
0.60 |
0.02 |
0.04 |
0.05 |
0.06 |
0.14 |
0.16 |
0.04 |
0.06 |
0.18 |
0.26 |
0.15 |
0.35 |
Skin enclosure |
0.10 |
0.14 |
0.33 |
0.20 |
0.07 |
0.35 |
0.42 |
0.17 |
0.31 |
0.17 |
0.09 |
0.43 |
1.02 |
1.44 |
1.02 |
0.22 |
1.03 |
1.26 |
Total nonabsorbed dose |
75.38 |
85.57 |
79.35 |
74.96 |
70.40 |
71.48 |
72.83 |
69.24 |
67.39 |
60.94 |
72.56 |
69.38 |
103.02 |
101.29 |
100.93 |
97.68 |
101.44 |
95.10 |
Urine |
ND |
ND |
0.01a |
0.02 |
0.06a |
0.16 |
ND |
ND |
0.01 |
0.01 |
0.02 |
0.05 |
ND |
ND |
ND |
0.01 |
0.01 |
0.01 |
Faeces |
ND |
ND/NS |
ND |
ND/NS |
ND |
0.01 |
ND/NS |
ND/NS |
ND/NS |
ND/NS |
ND/NS |
0.01a |
ND/NS |
0.01c |
ND/NS |
ND/NS |
ND/NS |
ND |
Cage wash |
ND |
ND |
ND |
ND |
ND |
0.02b |
ND |
ND |
0.01c |
ND |
ND |
ND |
ND |
ND |
ND |
ND |
ND |
ND |
Cage wipe |
ND |
ND |
0.01a |
0.01 |
0.01 |
0.01 |
ND |
0.01c |
0.01c |
0.01b |
0.01 |
0.01 |
0.01c |
0.01b |
ND |
0.01b |
ND |
0.01b |
Total excreted |
ND |
ND |
0.01 |
0.02 |
0.06 |
0.18 |
ND |
0.01 |
0.01 |
0.01 |
0.02 |
0.05 |
0.01 |
0.01 |
ND |
0.01 |
0.01 |
0.01 |
Carcass |
ND |
ND |
ND |
ND |
0.08 |
0.14 |
ND |
ND |
0.01 |
ND |
ND |
0.03 |
ND |
ND |
ND |
ND |
ND |
ND |
Skin |
5.63 |
3.18 |
4.57 |
5.05 |
7.88 |
3.79 |
3.04 |
3.48 |
5.67 |
9.93 |
8.86 |
4.46 |
0.56 |
0.93 |
1.11 |
1.48 |
1.44 |
1.52 |
Total absorbed dose |
5.63 |
3.18 |
4.57 |
5.07 |
8.02 |
4.11 |
3.04 |
3.48 |
5.68 |
9.93 |
8.88 |
4.54 |
0.56 |
0.93 |
1.11 |
1.48 |
1.44 |
1.52 |
Total recovery |
81.01 |
88.75 |
83.92 |
80.03 |
78.42 |
75.59 |
75.87 |
72.72 |
73.07 |
70.87 |
81.44 |
73.92 |
103.58 |
102.22 |
102.04 |
99.16 |
102.88 |
96.62 |
NS Not sampled ND Not detectable a Mean of three animals b Mean of two animals c Mean of one animal |
||||||||||||||||||
|
Table A6_2-2: Concentations of radioactivity in blood from male rats following a single dermal application of (14C)-ziram |
||||||
|
||||||
Dose level |
µg ziram/g |
|||||
0.5 h |
1 h |
2 h |
4 h |
10 h |
24 h |
|
1.07 mg |
0.002 |
ND |
ND |
ND |
0.002 |
0.006 .006 |
11.9 mg |
ND |
ND |
ND |
ND |
ND |
ND |
90.6 mg |
ND |
ND |
ND |
ND |
ND |
ND |
ND Not detectable |
Description of key information
O-isobutyl ethylthiocarbamate has not bioaccumulation potential.
The chemical belongs to the thiocarbamate group. In general, thiocarbamates are absorbed via the skin, mucous membranes, respiratory and gastrointestinal tracts, with rapid elimination via expired air and urine. Thiocarbamates are also rapidly metabolised, producing either mercapturic acid compounds or compounds that enter the carbon metabolic pool.
As a general rule, thiocarbamates can be absorbed by theorganism via the skin, mucous membranes, and the respiratory andgastrointestinal tracts. They are eliminated quite rapidly,mainly via expired air and urine.
Two major pathways exist for the metabolism ofthiocarbamates in mammals. One is via sulfoxidation andconjugation with glutathione. The conjugation product is thencleaved to a cysteine derivative, which is metabolized to amercapturic acidcompound. The second route is oxidation of thesulfur to a sulfoxide, which is then oxidized to a sulfone, orhydroxylation to compounds that enter the carbon metabolic pool.
In plants, thiocarbamates are rapidly metabolized in typicaloxidation reactions, e.g., thiol sulfur oxidation to the corres-ponding sulfoxides, reactive intermediates that are capable of reacting with sulfhydryl groups (as in glutathione, cysteine)to form conjugates. Onhydrolysis, mercaptans, carbon dioxide,and alkylamines may be formed.
While thiocarbamates and their metabolic products can befound in certain organs, such as liver and kidneys, accumulationdoes not take place because of their rapid metabolism.
Therefore testing for Basic toxicokinetics does not need to be performed.
References
World Health Orgnization Geneva, 1988,THIOCARBAMATE PESTICIDES - A GENERAL INTRODUCTION
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
- Absorption rate - dermal (%):
- 1
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.